Sandra Dios-Barbeito

Dr. Sandra Dios-Barbeito

Hospital Universitario Virgen del Rocío (Sevilla, Spain)
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
PCPatricia de la Cruz-Ojeda
Patricia de la Cruz-Ojeda
RFRocío Flores-Campos
Rocío Flores-Campos
SDSandra Dios-Barbeito
Sandra Dios-Barbeito
ENElena Navarro-Villarán
Elena Navarro-Villarán
Jordi MuntanéJordi Muntané
Jordi Muntané
Nitric oxide (NO) has been identified and described as a dual mediator in cancer according to dose-, time- and compartment-dependent NO generation. The present review addresses the different epigenetic mechanisms, such as histone modifications and non-coding RNAs (ncRNAs), miRNA and lncRNA, which regulate directly or indirectly nitric oxide synthase (NOS) expression and NO production, impacting all hallmarks of the oncogenic process. Among lncRNA, HEIH and UCA1 develop their oncogenic functions by inhibiting their target miRNAs and consequently reversing the inhibition of NOS and promoting tumor proliferation. The connection between miRNAs and NO is also involved in two important features in cancer, such as the tumor microenvironment that includes key cellular components such as tumor-associated macrophages (TAMs), cancer associated fibroblasts (CAFs) and cancer stem cells (CSCs).

13 August 2020 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
EPEduardo Perea del Pozo
Eduardo Perea del Pozo
DADaniel Aparicio-Sánchez
Daniel Aparicio-Sánchez
FRFátima Hinojosa Ramírez
Fátima Hinojosa Ramírez
FCFelipe Pareja Ciuró
Felipe Pareja Ciuró
VMVirginia Durán Muñoz-Cruzado
Virginia Durán Muñoz-Cruzado
JPJavier Padillo
Javier Padillo
Click on the article title to read more.

2 March 2021 in Colorectal Disease
Verified
Journal Article
Closed access
PDF file
FPFernando de la Portilla
Fernando de la Portilla
SDSandra Dios-Barbeito
Sandra Dios-Barbeito
MMMaría Victoria Maestre‐Sánchez
María Victoria Maestre‐Sánchez
JVJorge Manuel Vázquez‐Monchul
Jorge Manuel Vázquez‐Monchul
AGAna María García‐Cabrera
Ana María García‐Cabrera
MRMaría Luisa Reyes‐Díaz
María Luisa Reyes‐Díaz

Verified
Journal Article
Open access
PDF file
FCFrancisco José Calero Castro
Francisco José Calero Castro
SPSheila Pereira
Sheila Pereira
ILIman Laga
Iman Laga
PVPaula Villanueva
Paula Villanueva
GSGonzalo Suárez-Artacho
Gonzalo Suárez-Artacho
JPJavier Padillo-Ruiz
Javier Padillo-Ruiz
Circulating Tumor Cells (CTCs) are considered a prognostic marker in pancreatic cancer. In this study we present a new approach for counting CTCs and CTC clusters in patients with pancreatic cancer using the IsofluxTM System with the Hough transform algorithm (Hough-IsofluxTM). The Hough-IsofluxTM approach is based on the counting of an array of pixels with a nucleus and cytokeratin expression excluding the CD45 signal. Total CTCs including free and CTC clusters were evaluated in healthy donor samples mixed with pancreatic cancer cells (PCCs) and in samples from patients with pancreatic ductal adenocarcinoma (PDAC). The IsofluxTM System with manual counting was used in a blinded manner by three technicians who used Manual-IsofluxTM as a reference. The accuracy of the Hough-IsofluxTM approach for detecting PCC based on counted events was 91.00% [84.50, 93.50] with a PCC recovery rate of 80.75 ± 16.41%. A high correlation between the Hough-IsofluxTM and Manual-IsofluxTM was observed for both free CTCs and for clusters in experimental PCC (R2 = 0.993 and R2 = 0.902 respectively). However, the correlation rate was better for free CTCs than for clusters in PDAC patient samples (R2 = 0.974 and R2 = 0.790 respectively). In conclusion, the Hough-IsofluxTM approach showed high accuracy for the detection of circulating pancreatic cancer cells. A better correlation rate was observed between Hough-IsofluxTM approach and with the Manual-IsofluxTM for isolated CTCs than for clusters in PDAC patient samples.

27 April 2023 in Colorectal Disease
Verified
Journal Article
Closed access
FPF. de la Portilla
F. de la Portilla
VSV. Sojo
V. Sojo
JVJ. M. Vázquez‐Monchul
J. M. Vázquez‐Monchul
JPJ. Pintor‐Tortolero
J. Pintor‐Tortolero
SDSandra Dios-Barbeito
Sandra Dios-Barbeito
MRM. L. Reyes‐Díaz
M. L. Reyes‐Díaz

1 March 2018 in Transplantation Proceedings
Verified
Journal Article
Closed access
PDF file
SDSandra Dios-Barbeito
Sandra Dios-Barbeito
MDM. Domínguez-Bastante
M. Domínguez-Bastante
AMA. Moreno-Navas
A. Moreno-Navas
FLF.J. León-Díaz
F.J. León-Díaz
YFY. Fundora-Suárez
Y. Fundora-Suárez
MGM.á. Gómez-Bravo
M.á. Gómez-Bravo